Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2208087

N.Nc1cccc2c(O)cccc12

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.70
EP300 Q09472 2/20 0.70
KAT2B Q92831 2/20 0.70
KAT8 Q9H7Z6 2/20 0.70
HDAC3 O15379 1/20 0.70
NCOR2 Q9Y618 1/20 0.70
TSHR P16473 4/20 0.65
HPGD P15428 4/20 0.65
HSD17B10 Q99714 4/20 0.65
ALDH1A1 P00352 4/20 0.65
CYP3A4 P08684 3/20 0.65
TDP1 Q9NUW8 3/20 0.65
ALOX15 P16050 2/20 0.52
NR4A2 P43354 1/20 0.50
CDK2 P24941 1/20 0.48
MAPT P10636 2/20 0.48
CYP1A2 P05177 2/20 0.48
RECQL P46063 2/20 0.48
APP P05067 1/20 0.48
THRB P10828 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485855 0.97 IDO1 (0.73) IDO1EP300KAT2BKAT8HDAC3
SCHEMBL8371459 0.97 IDO1 (0.73) IDO1EP300KAT2BKAT8HDAC3
SCHEMBL29393764 0.97 IDO1 (0.73) IDO1EP300KAT2BKAT8HDAC3
SCHEMBL8006509 0.97 IDO1 (0.73) IDO1EP300KAT2BKAT8HDAC3
SCHEMBL29702452 0.97 IDO1 (0.73) IDO1EP300KAT2BKAT8HDAC3
SCHEMBL29706585 0.95 IDO1 (0.70) IDO1EP300KAT2BKAT8HDAC3
Hydrochloric Acid SCHEMBL28651123 0.95 IDO1 (0.70) IDO1EP300KAT2BKAT8HDAC3
SCHEMBL7991048 0.88 IDO1 (0.55) IDO1EP300KAT2BKAT8HDAC3
Putrescine SCHEMBL7991111 0.85 IDO1 (0.57) IDO1EP300KAT2BKAT8HDAC3
4-Aminophenol SCHEMBL9806770 0.85 IDO1 (0.57) IDO1EP300KAT2BKAT8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981883-B2 Substituted spiro-compounds and the use thereof for producing medicaments GRUENENTHAL GMBH (DE) 2011-07-19 US disclosed
US-20090275628-A1 Substituted Spiro-Compounds And The Use Thereof For Producing Medicaments GRUENENTHAL GMBH (DE) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275628-A1 Substituted Spiro-Compounds And The Use Thereof For Producing Medicaments REN, PKD1, PKD2 IDO1 4585/4885EP300 421/4885KAT2B 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.